• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

遗传神经发育障碍中的脑线粒体生物能量学:聚焦唐氏综合征、雷特综合征和脆性X综合征。

Brain Mitochondrial Bioenergetics in Genetic Neurodevelopmental Disorders: Focus on Down, Rett and Fragile X Syndromes.

作者信息

Valenti Daniela, Vacca Rosa Anna

机构信息

Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies (IBIOM), National Research Council (CNR), Via G. Amendola 122/O, 70126 Bari, Italy.

出版信息

Int J Mol Sci. 2023 Aug 6;24(15):12488. doi: 10.3390/ijms241512488.

DOI:10.3390/ijms241512488
PMID:37569863
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10419900/
Abstract

Mitochondria, far beyond their prominent role as cellular powerhouses, are complex cellular organelles active as central metabolic hubs that are capable of integrating and controlling several signaling pathways essential for neurological processes, including neurogenesis and neuroplasticity. On the other hand, mitochondria are themselves regulated from a series of signaling proteins to achieve the best efficiency in producing energy, in establishing a network and in performing their own de novo synthesis or clearance. Dysfunctions in signaling processes that control mitochondrial biogenesis, dynamics and bioenergetics are increasingly associated with impairment in brain development and involved in a wide variety of neurodevelopmental disorders. Here, we review recent evidence proving the emerging role of mitochondria as master regulators of brain bioenergetics, highlighting their control skills in brain neurodevelopment and cognition. We analyze, from a mechanistic point of view, mitochondrial bioenergetic dysfunction as causally interrelated to the origins of typical genetic intellectual disability-related neurodevelopmental disorders, such as Down, Rett and Fragile X syndromes. Finally, we discuss whether mitochondria can become therapeutic targets to improve brain development and function from a holistic perspective.

摘要

线粒体,远不止是作为细胞动力源的突出作用,它们是复杂的细胞器,作为核心代谢枢纽发挥作用,能够整合和控制神经过程所必需的多种信号通路,包括神经发生和神经可塑性。另一方面,线粒体自身受一系列信号蛋白的调控,以在产生能量、建立网络以及进行自身的从头合成或清除方面实现最佳效率。控制线粒体生物发生、动力学和生物能量学的信号传导过程功能障碍,越来越多地与脑发育受损相关,并涉及多种神经发育障碍。在此,我们综述了近期证据,证明线粒体作为脑生物能量学主要调节因子的新作用,突出它们在脑神经发育和认知中的调控技能。我们从机制角度分析线粒体生物能量功能障碍与典型遗传性智力残疾相关神经发育障碍(如下丘脑、雷特和脆性X综合征)起源的因果关联。最后,我们从整体角度讨论线粒体是否可成为改善脑发育和功能的治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4eb/10419900/b97c250566e2/ijms-24-12488-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4eb/10419900/f13b7e02707e/ijms-24-12488-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4eb/10419900/b97c250566e2/ijms-24-12488-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4eb/10419900/f13b7e02707e/ijms-24-12488-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4eb/10419900/b97c250566e2/ijms-24-12488-g002.jpg

相似文献

1
Brain Mitochondrial Bioenergetics in Genetic Neurodevelopmental Disorders: Focus on Down, Rett and Fragile X Syndromes.遗传神经发育障碍中的脑线粒体生物能量学:聚焦唐氏综合征、雷特综合征和脆性X综合征。
Int J Mol Sci. 2023 Aug 6;24(15):12488. doi: 10.3390/ijms241512488.
2
Mitochondrial dysfunction as a central actor in intellectual disability-related diseases: an overview of Down syndrome, autism, Fragile X and Rett syndrome.线粒体功能障碍作为智力障碍相关疾病的核心因素:唐氏综合征、自闭症、脆性 X 综合征和雷特综合征概述。
Neurosci Biobehav Rev. 2014 Oct;46 Pt 2:202-17. doi: 10.1016/j.neubiorev.2014.01.012. Epub 2014 Feb 15.
3
Mitochondrial biogenesis: pharmacological approaches.线粒体生物合成:药理学方法。
Curr Pharm Des. 2014;20(35):5507-9. doi: 10.2174/138161282035140911142118.
4
Inhibition of Drp1-mediated mitochondrial fission improves mitochondrial dynamics and bioenergetics stimulating neurogenesis in hippocampal progenitor cells from a Down syndrome mouse model.抑制 Drp1 介导线粒体分裂可改善线粒体动力学和生物能量学,从而刺激唐氏综合征小鼠模型中海马祖细胞的神经发生。
Biochim Biophys Acta Mol Basis Dis. 2017 Dec;1863(12):3117-3127. doi: 10.1016/j.bbadis.2017.09.014. Epub 2017 Sep 20.
5
The polyphenols resveratrol and epigallocatechin-3-gallate restore the severe impairment of mitochondria in hippocampal progenitor cells from a Down syndrome mouse model.多酚白藜芦醇和表没食子儿茶素-3-没食子酸酯可恢复唐氏综合征小鼠模型海马祖细胞中线粒体的严重损伤。
Biochim Biophys Acta. 2016 Jun;1862(6):1093-104. doi: 10.1016/j.bbadis.2016.03.003. Epub 2016 Mar 7.
6
Mitochondria as pharmacological targets in Down syndrome.唐氏综合征中的线粒体作为药物作用靶点。
Free Radic Biol Med. 2018 Jan;114:69-83. doi: 10.1016/j.freeradbiomed.2017.08.014. Epub 2017 Aug 31.
7
Brain development and bioenergetic changes.大脑发育和生物能量变化。
Neurobiol Dis. 2024 Sep;199:106550. doi: 10.1016/j.nbd.2024.106550. Epub 2024 Jun 6.
8
Emerging roles of brain metabolism in cognitive impairment and neuropsychiatric disorders.大脑代谢在认知障碍和神经精神障碍中的新兴作用。
Neurosci Biobehav Rev. 2022 Nov;142:104892. doi: 10.1016/j.neubiorev.2022.104892. Epub 2022 Sep 28.
9
Impaired Brain Mitochondrial Bioenergetics in the Ts65Dn Mouse Model of Down Syndrome Is Restored by Neonatal Treatment with the Polyphenol 7,8-Dihydroxyflavone.在唐氏综合征 Ts65Dn 小鼠模型中,大脑线粒体生物能量学受损,通过用多酚 7,8 - 二羟基黄酮进行新生儿治疗得以恢复。
Antioxidants (Basel). 2021 Dec 28;11(1):62. doi: 10.3390/antiox11010062.
10
Mitochondrial bioenergetics of astrocytes in Fragile X syndrome: new perspectives on culture conditions and sex effects.脆性 X 综合征星形胶质细胞的线粒体生物能学:培养条件和性别影响的新视角。
Am J Physiol Cell Physiol. 2022 Feb 1;322(2):C125-C135. doi: 10.1152/ajpcell.00130.2021. Epub 2021 Nov 24.

引用本文的文献

1
Neuroglobin: A promising candidate to treat neurological diseases.神经球蛋白:治疗神经系统疾病的一个有前景的候选物质。
Neural Regen Res. 2025 Jun 19. doi: 10.4103/NRR.NRR-D-24-01503.
2
Interactome of FMRP-N-tat therapeutic unveils key interactions for cellular function in Fragile X neurons.FMRP-N端蛋白治疗的相互作用组揭示了脆性X神经元细胞功能的关键相互作用。
J Biol Chem. 2025 Jun 4;301(7):110341. doi: 10.1016/j.jbc.2025.110341.
3
Advance in peptide-based drug development: delivery platforms, therapeutics and vaccines.基于肽的药物研发进展:递送平台、治疗药物与疫苗

本文引用的文献

1
Mitochondria as central hubs in synaptic modulation.线粒体作为突触调节的中心枢纽。
Cell Mol Life Sci. 2023 Jun 2;80(6):173. doi: 10.1007/s00018-023-04814-8.
2
Dietary Polyphenols as a Protection against Cognitive Decline: Evidence from Animal Experiments; Mechanisms and Limitations.膳食多酚对认知能力下降的保护作用:来自动物实验的证据、机制及局限性
Antioxidants (Basel). 2023 May 5;12(5):1054. doi: 10.3390/antiox12051054.
3
Neuronal and astrocyte determinants of critical periods of plasticity.神经元和星形胶质细胞对可塑性关键期的决定作用。
Signal Transduct Target Ther. 2025 Mar 5;10(1):74. doi: 10.1038/s41392-024-02107-5.
4
Targeting Mitochondrial Dysfunction in Cerebral Ischemia: Advances in Pharmacological Interventions.针对脑缺血中线粒体功能障碍:药理学干预进展
Antioxidants (Basel). 2025 Jan 18;14(1):108. doi: 10.3390/antiox14010108.
5
The 9 bp Deletion between the Mitochondrial COII and Lysine tRNA Genes in a Caucasian Population with Cognitive Disorders: An Observational Study.高加索人群认知障碍与线粒体 COII 和赖氨酸 tRNA 基因间 9 个碱基缺失:一项观察性研究。
Int J Mol Sci. 2024 Oct 9;25(19):10826. doi: 10.3390/ijms251910826.
6
Pharmacological inhibition of the CB1 cannabinoid receptor restores abnormal brain mitochondrial CB1 receptor expression and rescues bioenergetic and cognitive defects in a female mouse model of Rett syndrome.药理学抑制 CB1 大麻素受体可恢复雷特综合征女性小鼠模型异常的脑线粒体 CB1 受体表达,并挽救其能量代谢和认知缺陷。
Mol Autism. 2024 Sep 19;15(1):39. doi: 10.1186/s13229-024-00617-1.
7
Biomaterials targeting the microenvironment for spinal cord injury repair: progression and perspectives.针对脊髓损伤修复微环境的生物材料:进展与展望
Front Cell Neurosci. 2024 May 9;18:1362494. doi: 10.3389/fncel.2024.1362494. eCollection 2024.
8
PGC-1α integrates insulin signaling with mitochondrial physiology and behavior in a Drosophila model of Fragile X Syndrome.在脆性X综合征的果蝇模型中,PGC-1α将胰岛素信号与线粒体生理和行为整合在一起。
NPJ Metab Health Dis. 2024;2. doi: 10.1038/s44324-024-00004-7. Epub 2024 Feb 21.
9
2023 FDA TIDES (Peptides and Oligonucleotides) Harvest.2023年美国食品药品监督管理局肽和寡核苷酸采集活动
Pharmaceuticals (Basel). 2024 Feb 13;17(2):243. doi: 10.3390/ph17020243.
10
Trofinetide-a new chapter in rett syndrome's treatment.曲非奈肽——雷特综合征治疗的新篇章。
Front Pharmacol. 2023 Nov 16;14:1284035. doi: 10.3389/fphar.2023.1284035. eCollection 2023.
Trends Neurosci. 2023 Jul;46(7):566-580. doi: 10.1016/j.tins.2023.04.005. Epub 2023 May 16.
4
Aneuploidy effects on human gene expression across three cell types.三种细胞类型中人类基因表达的非整倍体效应。
Proc Natl Acad Sci U S A. 2023 May 23;120(21):e2218478120. doi: 10.1073/pnas.2218478120. Epub 2023 May 16.
5
Deregulation of ER-mitochondria contact formation and mitochondrial calcium homeostasis mediated by VDAC in fragile X syndrome.脆性 X 综合征中通过 VDAC 调节内质网-线粒体接触形成和线粒体钙稳态。
Dev Cell. 2023 Apr 10;58(7):597-615.e10. doi: 10.1016/j.devcel.2023.03.002.
6
Serious Games in the new era of digital-health interventions: A narrative review of their therapeutic applications to manage neurobehavior in neurodevelopmental disorders.数字健康干预新时代的严肃游戏:对其在神经发育障碍中管理神经行为的治疗应用的叙述性综述。
Neurosci Biobehav Rev. 2023 Jun;149:105156. doi: 10.1016/j.neubiorev.2023.105156. Epub 2023 Apr 3.
7
Mitochondrial Modulators: The Defender.线粒体调节剂:守护者。
Biomolecules. 2023 Jan 24;13(2):226. doi: 10.3390/biom13020226.
8
Cross-talk between energy and redox metabolism in astrocyte-neuron functional cooperation.星形胶质细胞-神经元功能合作中的能量和氧化还原代谢的串扰。
Essays Biochem. 2023 Mar 3;67(1):17-26. doi: 10.1042/EBC20220075.
9
Cell type characterization of spatiotemporal gene co-expression modules in Down syndrome brain.唐氏综合征大脑中时空基因共表达模块的细胞类型特征分析
iScience. 2022 Dec 28;26(1):105884. doi: 10.1016/j.isci.2022.105884. eCollection 2023 Jan 20.
10
Mitochondrial genetics in mental disorders: The bioenergy viewpoint.精神障碍中的线粒体遗传学:生物能量视角。
Eur Neuropsychopharmacol. 2023 Feb;67:80-82. doi: 10.1016/j.euroneuro.2022.12.004. Epub 2023 Jan 12.